@incollection{, 18F1C29917179F9F26B87E4DA85C3C85 , author={{JanTesarik}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}20857 } @incollection{b0, , title={{Melatonin as a potential adjuvant treatment}} , author={{ RZhang } and { XWang } and { LNi }} 10.1016/j.lfs.2020.117583 , journal={{Life Sci}} 250 117583 , year={2020} } @incollection{b1, , title={{Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study}} , author={{ LLRen } and { YMWang } and { ZQWu }} 10.1097/CM9 , journal={{Chin Med J (Engl)}} 133 9 , year={2020} } @incollection{b2, , title={{Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review}} , author={{ JMSanders } and { MLMonogue } and { TZJodlowski } and { JBCutrell }} 10.1097/cm9.0000000000000722 , journal={{JAMA}} , year={2020} } @book{b3, , title={{}} 10.1097/cm9.0000000000000722 323 } @book{b4, , title={{Potential utility of melatonin in deadly infectious diseases related to the overreaction of innate immune response and destructive inflammation: focus on}} , author={{ D-XTan } and { RHardeland }} 10.1097/cm9.0000000000000722 COVID-19 } @incollection{b5, , title={{}} 10.32794/mr11250052 , journal={{Melatonin Res}} 3 1 , year={2020} } @book{b6, , title={{Treatment of Ebola and other infectious diseases: melatonin "goes viral}} , author={{ RJReiter } and { QMa } and { RSharma }} } @incollection{b7, , title={{}} 10.32794/mr11250047 , journal={{Melatonin Res}} 3 1 , year={2020} } @incollection{b8, , author={{ AJerez-Calero } and { SalvatierraCuenca } and { MTBenitez -Feliponi } and { AFernández-Marín } and { CENarbona-López } and { E } and { UberosFernández } and { JMuñoz-Hoyos } and { A }} 10.1097/PCC.0000000000002346 doi: 10.1097/PCC.0000000000002346 , booktitle={{Hypothermia plus melatonin in asphyctic newborns: a randomized-controlled pilot study}} , year={2020} } @incollection{b9, , title={{on behalf of the HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression}} , author={{ PMehta } and { DFMcauley } and { MBrown } and { ESanchez } and { RSTattersall } and { JJManson }} 10.1097/pcc.0000000000002346 , journal={{Lancet}} 395 , year={2020. 10229} } @incollection{b10, , title={{Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?}} , author={{ AIRitchie } and { ASinganayagam }} 10.1016/S0140-6736(20)30691-7 , journal={{Lancet}} 395 1111 , year={2020. 10230} } @incollection{b11, , title={{The history and fate of the gold standard}} , author={{ DSJones } and { SHPodolsky }} 10.1016/S0140-6736(15)60742-5 , journal={{Lancet}} 385 9977 , year={2015} } @incollection{b12, , title={{Interpretation of the breast screening trials: a commentary on the recent paper by Gøtzsche and Olsen}} , author={{ SWDuffy }} 10.1054/brst.2000.0238 , journal={{Breast}} 10 3 , year={2001} } @incollection{b13, , title={{Randomised controlled trials for Ebola: practical and ethical issues}} , author={{ CAdebamowo } and { OBah-Sow } and { FBinka }} 10.1016/S0140-6736(14)61734-7 , journal={{Lancet}} 384 9952 , year={2014} } @incollection{b14, , title={{Can melatonin reduce the severity of COVID-19 pandemic?}} , author={{ AShneider } and { AKudriavtsev } and { AVakhrusheva }} 10.1080/08830185.2020.1756284 , journal={{Int Rev Immunol}} , year={2020} } @incollection{b15, , title={{Melatonin for the prevention and treatment of cancer}} , author={{ YLi } and { SLi } and { YZhou } and { XMeng } and { JJZhang } and { DPXu } and { HBLi }} 10.18632/oncotarget.16379 , journal={{Oncotarget}} 8 24 , year={2017} }